Return to study ST003043 main page

MB Sample ID: SA330395

Local Sample ID:Serum3DMN4negative
Subject ID:SU003158
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Gender:Female

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU003158
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Gender:Female

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
Serum3DMN4negativeSA330395FL039091MutantGenotype
Serum3DMN4negativeSA330395FL039091tamoxifen, 3dayTreatment

Collection:

Collection ID:CO003151
Collection Summary:serum and kidney were obtained from GCERRARaD females 3 days or 3 months post-tam (n=5/group) and age-matched wild-type females (n=4)
Sample Type:Kidney; Serum

Treatment:

Treatment ID:TR003167
Treatment Summary:Mutant and wild-type female mice were treated with tamoxifen for 3 days or 3 months.

Sample Preparation:

Sampleprep ID:SP003164
Sampleprep Summary:To extract metabolites, frozen kidney cortices were weighed, and ca 20 mg of each cortex was added to a tube containing 650 μL of 80% methanol (diluted in dH2O). Sample tubes were placed in a bead homogenizer for 1 minute at a frequency of 30/s. Samples were then placed in a -20℃ freezer for 10 minutes, centrifuged for 10 minutes at 15,000 RPM in 4℃, and the supernatant was moved to a new tube. The remaining pellets were then re-extracted with 400 μL of 80% methanol, following the above procedure of homogenization and centrifugation. The supernatant was then added to the supernatant pool obtained from the first extraction. The pellet was re-extracted for a third time using 350 μL of 80% MeOH and supernatant was again added to the pool from the first two extractions. The supernatant pool was placed at -20℃ for 15 minutes, centrifuged for 20 minutes at 15,000 RPM, and transferred to a new tube. The methanolic extract samples were speed-vacuumed and reconstituted in 70% acetonitrile (diluted in dH2O) containing 0.025% acetic acid at a protein concentration of 3μg/μL. For serum preparation, samples were diluted 10-fold with 70% acetonitrile (diluted in dH2O) containing 0.025% acetic acid, and centrifuged for 20 minutes at 20,000 g.

Combined analysis:

Analysis ID AN004992
Analysis type MS
Chromatography type HILIC
Chromatography system Agilent 1290 Infinity II
Column MicroSolv Cogent Diamond Hydride (150 × 2.1 mm, 4.0 um)
MS Type ESI
MS instrument type QTOF
MS instrument name Agilent 6550 QTOF
Ion Mode UNSPECIFIED
Units abundance

Chromatography:

Chromatography ID:CH003771
Instrument Name:Agilent 1290 Infinity II
Column Name:MicroSolv Cogent Diamond Hydride (150 × 2.1 mm, 4.0 um)
Column Temperature:25
Flow Gradient:0-1 min, 99% B; 1-15 min, a linear gradient to 20% B; 15.1-29 min, 0% B; 29.1-37 min, 99% B
Flow Rate:0.4mL/min
Solvent A:6 uM edta and 0.025% acetic acid in isopropanol:H2O (50:50)
Solvent B:6 uM edta and 5mM ammonium acetate in CH3CN: H2O (90:10)
Chromatography Type:HILIC

MS:

MS ID:MS004732
Analysis ID:AN004992
Instrument Name:Agilent 6550 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:The serum samples have negative and positive mode data. The kidney samples have negative mode data. MassHunter B10 MassHunter B10 MassHunter Profinder (B10)
Ion Mode:UNSPECIFIED
  logo